![]() | |
Abbreviation | ISTT |
---|---|
Formation | 2006 |
Founder | Lluís Montoliu, Belén Pintado |
Founded at | 2006 in Spain (incorporated in 2013 in the USA) |
Type | Scientific society |
Purpose | To foster and stimulate research, communication, and technology exchange in transgenic technologies |
Headquarters | Buffalo, New York, USA |
Region served | Worldwide |
Membership | 664 members (as of April 2024) |
President | Rebecca Haffner-Krausz |
Vice president | Aimee Stablewski, |
Main organ | Transgenic Research |
Website | www |
The International Society for Transgenic Technologies (ISTT) is an organization dedicated to advancing research, communication, and technology exchange regarding transgenic technologies. [1] [2]
Every one and a half years the ISTT organizes an international scientific conference, the Transgenic Technology Meeting, also known as the TT Meeting. [3] To promote communication and technology exchange, the website of the society publishes information and protocols related to transgenic technologies as well as the locations of transgenic service facilities, recognized as a valuable resource in the scientific literature. [9] [10] [11] [12] [13] A collection of ISTT subject-related protocols has been published in the book Advanced Protocols for Animal Transgenesis – an ISTT Manual. [2] The society is also associated with the peer-reviewed scientific journal Transgenic Research, which publishes scientific findings on transgenic and genome-edited higher model organisms. [14] [3] As a platform for the rapid exchange of scientific information, the ISTT hosts two mailing lists, the public transgenic-list (often referred to as tg-l) and the ISTT-list reserved for ISTT members with around 1500 and 660 participants (April 2024). [15] [16] [17]
Year | Venue | Country | Citation |
---|---|---|---|
2025 | Zurich | Switzerland | [18] |
2023 | Houston | USA | [19] |
2022 | Helsinki | Finland | [20] |
2020 | Rehovot | Israel | [21] |
2019 | Kobe | Japan | [22] |
2017 | Salt Lake City | USA | [23] |
2016 | Prague | Czech Republic | [24] |
2014 | Edinburgh | Scotland | [25] |
2013 | Guangzhou | China | [26] |
2011 | St. Pete Beach | USA | [27] |
2010 | Berlin | Germany | [28] |
2008 | Toronto | Canada | [29] |
2007 | Brisbane | Australia | [30] |
2005 | Barcelona | Spain | [31] |
2004 | Uppsala | Sweden | [32] |
2001 | Stockholm | Sweden | [18] |
The ISTT Prize recognizes individuals for their outstanding contributions to the field of transgenic technologies and is presented at the Transgenic Technology Meeting. Prominent winners included Ralph Brinster (2011), Janet Rossant (2014), Mario Capecchi (2017) and Rudolf Jaenisch (2025). [3] [25] [27] [33]
The ISTT Young Investigator Award recognizes outstanding achievements by young scientists whose work is advancing the field of transgenic technologies with new ideas and who have recently received an academic degree. The ISTT Young Investigator Award is presented at the Transgenic Technology Meetings. Prominent winners included Feng Zhang (2014) and Alexis Komor (2017) for their work on genome editing in model organisms. [3] [25]
The 3Rs Award recognizes outstanding achievements by a researcher or research team that advances the field of transgenic technologies with new methods and improvements in strict accordance with the 3Rs principles for reduction, refinement, and replacement of animals used in research. The prize is awarded during the Transgenic Technology Meetings. [34] [3]
A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. The exact definition of a genetically modified organism and what constitutes genetic engineering varies, with the most common being an organism altered in a way that "does not occur naturally by mating and/or natural recombination". A wide variety of organisms have been genetically modified (GM), including animals, plants, and microorganisms.
Genetic engineering, also called genetic modification or genetic manipulation, is the modification and manipulation of an organism's genes using technology. It is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to produce improved or novel organisms.
Genetically modified foods, also known as genetically engineered foods, or bioengineered foods are foods produced from organisms that have had changes introduced into their DNA using various methods of genetic engineering. Genetic engineering techniques allow for the introduction of new traits as well as greater control over traits when compared to previous methods, such as selective breeding and mutation breeding.
Molecular genetics is a branch of biology that addresses how differences in the structures or expression of DNA molecules manifests as variation among organisms. Molecular genetics often applies an "investigative approach" to determine the structure and/or function of genes in an organism's genome using genetic screens.
Mario Ramberg Capecchi is an Italian-born molecular geneticist and a co-awardee of the 2007 Nobel Prize in Physiology or Medicine for discovering a method to create mice in which a specific gene is turned off, known as knockout mice. He shared the prize with Martin Evans and Oliver Smithies. He is currently Distinguished Professor of Human Genetics and Biology at the University of Utah School of Medicine.
A transgene is a gene that has been transferred naturally, or by any of a number of genetic engineering techniques, from one organism to another. The introduction of a transgene, in a process known as transgenesis, has the potential to change the phenotype of an organism. Transgene describes a segment of DNA containing a gene sequence that has been isolated from one organism and is introduced into a different organism. This non-native segment of DNA may either retain the ability to produce RNA or protein in the transgenic organism or alter the normal function of the transgenic organism's genetic code. In general, the DNA is incorporated into the organism's germ line. For example, in higher vertebrates this can be accomplished by injecting the foreign DNA into the nucleus of a fertilized ovum. This technique is routinely used to introduce human disease genes or other genes of interest into strains of laboratory mice to study the function or pathology involved with that particular gene.
Exogenous DNA is DNA originating outside the organism of concern or study. Exogenous DNA can be found naturally in the form of partially degraded fragments left over from dead cells. These DNA fragments may then become integrated into the chromosomes of nearby bacterial cells to undergo mutagenesis. This process of altering bacteria is known as transformation. Bacteria may also undergo artificial transformation through chemical and biological processes. The introduction of exogenous DNA into eukaryotic cells is known as transfection. Exogenous DNA can also be artificially inserted into the genome, which revolutionized the process of genetic modification in animals. By microinjecting an artificial transgene into the nucleus of an animal embryo, the exogenous DNA is allowed to merge the cell's existing DNA to create a genetically modified, transgenic animal. The creation of transgenic animals also leads into the study of altering sperm cells with exogenous DNA.
Ralph Lawrence Brinster is an American geneticist, National Medal of Science laureate, and Richard King Mellon Professor of Reproductive Physiology at the School of Veterinary Medicine, University of Pennsylvania.
In molecular cloning and biology, a gene knock-in refers to a genetic engineering method that involves the one-for-one substitution of DNA sequence information in a genetic locus or the insertion of sequence information not found within the locus. Typically, this is done in mice since the technology for this process is more refined and there is a high degree of shared sequence complexity between mice and humans. The difference between knock-in technology and traditional transgenic techniques is that a knock-in involves a gene inserted into a specific locus, and is thus a "targeted" insertion. It is the opposite of gene knockout.
Cisgenesis is a product designation for a category of genetically engineered plants. A variety of classification schemes have been proposed that order genetically modified organisms based on the nature of introduced genotypical changes, rather than the process of genetic engineering.
Plant genetics is the study of genes, genetic variation, and heredity specifically in plants. It is generally considered a field of biology and botany, but intersects frequently with many other life sciences and is strongly linked with the study of information systems. Plant genetics is similar in many ways to animal genetics but differs in a few key areas.
Genetically modified animals are animals that have been genetically modified for a variety of purposes including producing drugs, enhancing yields, increasing resistance to disease, etc. The vast majority of genetically modified animals are at the research stage while the number close to entering the market remains small.
A genetically modified (GM) insect is an insect that has been genetically modified, either through mutagenesis, or more precise processes of transgenesis, or cisgenesis. Motivations for using GM insects include biological research purposes and genetic pest management. Genetic pest management capitalizes on recent advances in biotechnology and the growing repertoire of sequenced genomes in order to control pest populations, including insects. Insect genomes can be found in genetic databases such as NCBI, and databases more specific to insects such as FlyBase, VectorBase, and BeetleBase. There is an ongoing initiative started in 2011 to sequence the genomes of 5,000 insects and other arthropods called the i5k. Some Lepidoptera have been genetically modified in nature by the wasp bracovirus.
Genetically modified bacteria were the first organisms to be modified in the laboratory, due to their simple genetics. These organisms are now used for several purposes, and are particularly important in producing large amounts of pure human proteins for use in medicine.
Genetically modified fish are organisms from the taxonomic clade which includes the classes Agnatha, Chondrichthyes and Osteichthyes whose genetic material (DNA) has been altered using genetic engineering techniques. In most cases, the aim is to introduce a new trait to the fish which does not occur naturally in the species, i.e. transgenesis.
Genetic engineering is the science of manipulating genetic material of an organism. The first artificial genetic modification accomplished using biotechnology was transgenesis, the process of transferring genes from one organism to another, first accomplished by Herbert Boyer and Stanley Cohen in 1973. It was the result of a series of advancements in techniques that allowed the direct modification of the genome. Important advances included the discovery of restriction enzymes and DNA ligases, the ability to design plasmids and technologies like polymerase chain reaction and sequencing. Transformation of the DNA into a host organism was accomplished with the invention of biolistics, Agrobacterium-mediated recombination and microinjection. The first genetically modified animal was a mouse created in 1974 by Rudolf Jaenisch. In 1976 the technology was commercialised, with the advent of genetically modified bacteria that produced somatostatin, followed by insulin in 1978. In 1983 an antibiotic resistant gene was inserted into tobacco, leading to the first genetically engineered plant. Advances followed that allowed scientists to manipulate and add genes to a variety of different organisms and induce a range of different effects. Plants were first commercialized with virus resistant tobacco released in China in 1992. The first genetically modified food was the Flavr Savr tomato marketed in 1994. By 2010, 29 countries had planted commercialized biotech crops. In 2000 a paper published in Science introduced golden rice, the first food developed with increased nutrient value.
The Three Rs (3Rs) are guiding principles for more ethical use of animals in product testing and scientific research. They were first described by W. M. S. Russell and R. L. Burch in 1959. The 3Rs are:
Feng Zhang is a Chinese–American biochemist. Zhang currently holds the James and Patricia Poitras Professorship in Neuroscience at the McGovern Institute for Brain Research and in the departments of Brain and Cognitive Sciences and Biological Engineering at the Massachusetts Institute of Technology. He also has appointments with the Broad Institute of MIT and Harvard. He is most well known for his central role in the development of optogenetics and CRISPR technologies.
Margaret M. Perry (1930-2009) was an English molecular geneticist and embryology researcher at the University of Edinburgh whose research produced the first warm-blooded animal developed completely in vitro.
Gene stacking is the combination of more than one gene for plant disease resistance, or crop productivity, or other horticultural traits. In plant breeding traditionally that means breeding those genes in, but increasingly also can mean genetic engineering. This can be achieved a few different ways, and gene pyramiding is one of those methods. Stacking of transgenes is yet more difficult than stacking natural genes, but especially in the case of pest resistance genes which require a significant financial investment to insert, is advantageous over other methods. Pathosystems with rapid evolution in the pathogen have long been considered good targets of stacking, to broaden and prolong resistance.